# Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy

> **NCT04530240** · — · COMPLETED · sponsor: **University of Bologna** · enrollment: 4238 (actual)

## Conditions studied

- Liver Transplant Disorder
- HCC

## Interventions

- **PROCEDURE:** Liver Transplantation

## Key facts

- **NCT ID:** NCT04530240
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-01
- **Primary completion:** 2018-08-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 4238 (ACTUAL)
- **Last updated:** 2020-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530240, "Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04530240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*